Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 367,049Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Jevtana

PharmaCompass

01

Brand Name : Jevtana

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Cabazitaxel

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 528

2018 Revenue in Millions : 460

Growth (%) : 15

Sanofi Company Banner

02

Brand Name : Jevtana

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Cabazitaxel

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 648

2019 Revenue in Millions : 585

Growth (%) : 11

Sanofi Company Banner

03

Brand Name : Jevtana

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Cabazitaxel

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 501

2020 Revenue in Millions : 584

Growth (%) : -15

Sanofi Company Banner

04

Brand Name : Jevtana

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Cabazitaxel

Main Therapeutic Indication : Oncology

Currency : USD

2014 Revenue in Millions : 18.20%

2013 Revenue in Millions :

Growth (%) :

Sanofi Company Banner

05

Brand Name : Jevtana

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Cabazitaxel

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 300

2014 Revenue in Millions : 353

Growth (%) : 18%

Sanofi Company Banner

06

Brand Name : Jevtana

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Cabazitaxel

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 379

2015 Revenue in Millions : 340

Growth (%) : 12

Sanofi Company Banner

07

Brand Name : Jevtana

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Cabazitaxel

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 479

2016 Revenue in Millions : 444

Growth (%) : 8

Sanofi Company Banner

08

Brand Name : Jevtana

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Cabazitaxel

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 477

2017 Revenue in Millions : 436

Growth (%) : 9%

Sanofi Company Banner